Results 41 to 50 of about 3,173 (204)

A Possible Case of β‐Thalassemia From the Cemetery of Santa Maria Maggiore in Vercelli (Piedmont, Northern Italy,18th Century)

open access: yesInternational Journal of Osteoarchaeology, Volume 35, Issue 5, Page 341-350, September/October 2025.
ABSTRACT In Italy's Piedmont region, the city of Vercelli has a history of malaria transmission due to favorable conditions for Anopheles mosquitoes, which may have influenced the genetic prevalence of thalassemia. This study investigates the skeletal remains of a nonadult individual from the Church of Santa Maria Maggiore in Vercelli, dating to the ...
R. Fusco   +4 more
wiley   +1 more source

Microcytic anemia factor no estudo das anemias microcíticas [PDF]

open access: yes, 2010
A anemia ferropénica e a β-Talassemia menor são as anemias microcíticas mais frequentes na prática laboratorial, sendo o seu diagnóstico de extrema importância clínica.
Barros, Clara, Teixeira, Joana
core  

Determinação da sobrecarga de ferro na talassemia pela IRM hepática e ferritina [PDF]

open access: yes, 2008
Accumulation of iron in thalassemia causes organ damage and reduces patient survival due to heart lesions in the second decade of life. Iron deposits are monitored by direct (biopsy) and indirect methods (ferritin) with sequential data being better than ...
ANGULO, Ivan L.   +5 more
core   +2 more sources

Abstract Book for the 2nd Sickle Cell & Thalassaemia Virtual Conference

open access: yes, 2022
HemaSphere, Volume 6, Issue S1, Page 1-43, January 2022.
wiley   +1 more source

DESENVOLVIMENTO E VALIDAÇÃO DE UM MODELO PREDITIVO PARA ALFA-TALASSEMIA EM PORTADORES DE TRAÇO FALCIFORME BASEADO NA CONCENTRAÇÃO DA HBS

open access: yesHematology, Transfusion and Cell Therapy
Objetivo: Desenvolver modelo preditivo, usando a concentração da Hb S, como ferramenta de diagnóstico de alfa talassemia em portadores de traço falciforme. Metodologia: Foram analisados 241 indivíduos adultos com traço falciforme.
JPS Jaschke   +5 more
doaj   +1 more source

DIAGNÓSTICO MOLECULAR DE BETA TALASSEMIA INTERMÉDIA: RELATO DE HETEROZIGOTO COMPOSTO PARA MUTAÇÃO HBB:C.118C>T (CD39) E HBB:C.-138C>T (-88C>T)

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Demonstrar a relevância do diagnóstico molecular na identificação de heterozigoto composto para beta talassemias HBB:c.118C>T (CD39) e HBB:c.-138C>T (-88C>T) em recém-nascido da triagem neonatal.
VS Ramos   +8 more
doaj   +1 more source

Le Basi biochimiche e molecolari delle talassemie e la diagnosi dell'Alfa-talassemia eterozigote [PDF]

open access: yes, 1982
Recent aspects of molecular and biochemical basis of thalassemic syndromes are described together with laboratory methods suitable for diagnosis and screening of heterozygous α ...
Masala, Bruno Lucio
core  

EHA2021 Virtual Congress Abstract Book

open access: yes, 2021
HemaSphere, Volume 5, Issue S2, June 2021.
wiley   +1 more source

S144 A MULTICENTRE, RANDOMIZED, NON‐INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION‐DEPENDENT HEMOGLOBINOPATHIES (DEEP‐2 TRIAL)

open access: yesHemaSphere, Volume 3, Issue S1, Page 23-24, June 2019., 2019
Background: While the efficacy and safety of deferiprone (DFP) in adult patients with transfusion‐dependent hemoglobinopathies (TDH) has been extensively studied, data in children are sparse. Aims: We report results of DEferiprone Evaluation in Pediatrics‐2 (DEEP‐2), (EudraCT Number 2012‐000353‐31), a Phase III multicentre, randomized, open label study
A. Kattamis   +23 more
wiley   +1 more source

Clinical and laboratorial diversity in the bantu haplotype of sickle cell anemia [PDF]

open access: yes, 2006
Several factors have been identified as possibly being responsible for the diversity of sickle cell anemia patients symptoms, including gender, age, haplotypes and hemoglobin F levels.
Cipolotti, Rosana   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy